Schomerus G, Leonhard A, Manthey J et al. The stigma of alcohol-related liver disease and its impact on healthcare. J Hepatol 2022;77:516–524.

Article  PubMed  Google Scholar 

American Association for the Study of Liver Diseases, European Association for the Study of the Liver, Latin American Association for the Study of the Liver et al. Ending stigmatizing language in alcohol and liver disease: A liver societies’ statement. Hepatology 2023;78:1682–1683.

Centers for Disease Control and Prevention National Center for Injury Prevention and Control. Web-Based Injury Statistics Query and Reporting System (WISQARS), Vol 2021. CDC: Atlanta, 2017.

Ufere NN, Donlan J, Indriolo T et al. Burdensome transitions of care for patients with end-stage liver disease and their caregivers. Dig Dis Sci 2021;66:2942–2955.

Article  PubMed  Google Scholar 

Kaplan A, Comisar L, Ufere NN et al. Understanding prognosis: Discrepancy in prognosis estimates between patients with cirrhosis and their hepatologists. Clin Gastroenterol Hepatol 2023;21:1005–1012.

Article  PubMed  Google Scholar 

Gustot T, Stadlbauer V, Laleman W et al. Transition to decompensation and acute-on-chronic liver failure: role of predisposing factors and precipitating events. J Hepatol 2021;75(Suppl 1):S36–S48.

Article  PubMed  Google Scholar 

Peng JK, Hepgul N, Higginson IJ et al. Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis. Palliat Med 2019;33:24–36.

Article  PubMed  Google Scholar 

Hansen L, Chang MF, Hiatt S et al. Symptom frequency and distress underestimated in decompensated cirrhosis. Dig Dis Sci 2022;67:4234–4242.https://doi.org/10.1007/s10620-021-07216-7

Article  PubMed  Google Scholar 

Patel AA, Tapper EB, Kanwal F et al. Targets and study design for symptom-focused trials aimed at patients with cirrhosis: An expert consensus. Hepatol Commun 2023;7:e0135.

Article  PubMed  PubMed Central  Google Scholar 

Lago-Hernandez C, Nguyen NH, Khera R et al. Cost-related nonadherence to medications among US adults with chronic liver diseases. Mayo Clin Proc 2021;96:2639–2650.

Article  PubMed  Google Scholar 

Bajaj JS, Wade JB, Gibson DP et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol 2011;106:1646–1653.

Article  PubMed  PubMed Central  Google Scholar 

Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: Observational study. BMJ 2018;362:k2817.

Article  PubMed  PubMed Central  Google Scholar 

Philip G, Hookey L, Richardson H et al. Alcohol-associated liver disease is now the most common indication for liver transplant waitlisting among young American adults. Transplantation 2022;106:2000–2005.

Article  CAS  PubMed  Google Scholar 

Lai JC, Ufere NN, Bucuvalas JC. Liver transplant survivorship. Liver Transpl 2020;26:1030–1033.

Article  PubMed  PubMed Central  Google Scholar 

Haugen CE, Holscher CM, Garonzik-Wang J et al. National trends in liver transplantation in older adults. J Am Geriatr Soc 2018;66:2321–2326.

Article  PubMed  PubMed Central  Google Scholar 

Kwong AJ, Devuni D, Wang C et al. Outcomes of liver transplantation among older recipients with nonalcoholic steatohepatitis in a large multicenter US Cohort: The re-evaluating age limits in transplantation consortium. Liver Transpl 2020;26:1492–1503.

Article  PubMed  PubMed Central  Google Scholar 

Kochar B, Ufere NN, Ritchie CS et al. The 5Ms of geriatrics in gastroenterology: The path to creating age-friendly care for older adults with inflammatory bowel diseases and cirrhosis. Clin Transl Gastroenterol 2022;13:e00445.

Article  PubMed  PubMed Central  Google Scholar 

Su F, Yu L, Berry K et al. Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplantation outcomes, and transplant-related survival benefit. Gastroenterology 2016;150:441–453.

Article  PubMed  Google Scholar 

Ufere NN, El-Jawahri A, Ritchie C et al. Promoting prognostic understanding and health equity for patients with advanced liver disease: Using “best case/worst case.” Gastroenterology 2023;164:171–176.

Article  PubMed  Google Scholar 

Saly DL, Allegretti AS, Ufere NN, et al. The SILK Collaborative: A multidisciplinary approach to serious illness communication for patients with liver failure and acute kidney injury. Kidney360 2024 Feb 7. Online ahead of print.

Kaplan A, Fortune B, Ufere N et al. National trends in location of death in patients with end-stage liver disease. Liver Transpl 2021;27:165–176.

Article  PubMed  Google Scholar 

Macken L, Bremner S, Gage H et al. Randomised clinical trial: Palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis. Aliment Pharmacol Ther 2020;52:107–122.

Article  PubMed  Google Scholar 

Tandon P, Walling A, Patton H et al. AGA Clinical Practice Update on palliative care management in cirrhosis: Expert review. Clin Gastroenterol Hepatol 2021;19:646–656.

Article  PubMed  Google Scholar 

Rogal S, Hansen L, Patel A et al. AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis. Hepatology 2022;76:819–853.

Article  PubMed  Google Scholar 

Verma S, Hingwala J, Low JTS et al. Palliative clinical trials in advanced chronic liver disease: Challenges and opportunities. J Hepatol 2023;79:1236–1253.

Article  PubMed  Google Scholar 

Verma M, Kosinski AS, Volk ML et al. Introducing palliative care within the treatment of end-stage liver disease: The study protocol of a cluster randomized controlled trial. J Palliat Med 2019;22:34–43.

Article  PubMed  Google Scholar